Vincerx Pharma Inc. (VINC:OTC) closed at $0.013 on February 5, 2026, unchanged on the day. The stock trades 61.8% below its 52-week high of $0.034 and 1,200.0% above its 52-week low of $0.001. Vincerx Pharma Inc. is part of the Finance sector.
Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are primarily conducted in the United States. It focuses to develop, use, manufacture, commercialize, sublicense and distribute a clinical-stage and follow-on small molecule drug program and a preclinical stage bioconjugation/next-generation ADC platform.
Find more stocks like VINC with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.